Quick Summary:
In an ever-evolving global landscape, keeping atop of emerging trends, developments, and market shifts in the Antidepressants industry is crucial for strategic decision-making. The global antidepressants market, currently estimated at US$14.5 billion, is projected to ascend to an impressive US$17.6 billion by 2030, evidencing the growing demand and market potential.
This exclusive market research report offers a comprehensive analysis and inside look into the expanding antidepressant market. Gain industry-focused insights including individual analytics of key segments such as Major Depressive Disorder and Obsessive-Compulsive Disorder, as well as in-depth regional outlooks including key geographic markets like the U.S., China, Japan, and Canada. Understand competitive dynamics with percentages of market shares among key competitors like Allergan PLC, Eli Lilly and Company, and more. Stay ahead of the curve with online interactive peer-to-peer collaborative bespoke updates, access to digital archives, and complimentary updates for one year. Notably, your strategic decisions can influence and shape your company's trajectory in this rapidly growing and imperative market.
Global Antidepressants Market to Reach $17.6 Billion by 2030
The global market for Antidepressants estimated at US$14.5 Billion in the year 2022, is projected to reach a revised size of US$17.6 Billion by 2030, growing at a CAGR of 2.5% over the analysis period 2022-2030. Major Depressive Disorder, one of the segments analyzed in the report, is projected to record a 2.2% CAGR and reach US$7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Obsessive-Compulsive Disorder segment is readjusted to a revised 1.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 4.2% CAGR
The Antidepressants market in the U.S. is estimated at US$3.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 4.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 2.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2030.Select Competitors (Total 43 Featured) -
- Allergan PLC
- Eli Lilly and Company
- GlaxoSmithKline PLC
- H. Lundbeck A/S
- Merck & Co., Inc.
- Otsuka America Pharmaceutical, Inc.
- Pfizer, Inc.
- Takeda Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Antidepressants?
What is the growth rate of the Global Market for Antidepressants?
What is the forecasted size of the Global Market for Antidepressants?
Who are the key companies in the Global Market for Antidepressants?
| Report Attribute | Details |
|---|---|
| No. of Pages | 174 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 14.5 Billion |
| Forecasted Market Value ( USD | $ 17.6 Billion |
| Compound Annual Growth Rate | 2.5% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Allergan PLC
- Eli Lilly and Company
- GlaxoSmithKline PLC
- H. Lundbeck A/S
- Merck & Co., Inc.
- Otsuka America Pharmaceutical, Inc.
- Pfizer, Inc.
- Takeda Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
